[
    [
        {
            "time": "2018-01-10",
            "original_text": "恒瑞创新药有偿许可给美国公司 或将拓宽海外市场",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "创新药",
                    "美国公司",
                    "海外授权"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞创新药有偿许可给美国公司 或将拓宽海外市场",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-10",
            "original_text": "机构一致看好哪些股票？2018年1月10日机构一致看好10金股",
            "features": {
                "keywords": [
                    "机构一致看好",
                    "金股",
                    "投资主线"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "机构一致看好哪些股票？2018年1月10日机构一致看好10金股",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 2,
                "Headline_Structure": 8,
                "Source_Recency": 1
            }
        },
        {
            "time": "2018-01-10",
            "original_text": "掘金沪深股通：外资昨净买入78只个股超千万元 最爱这四个板块",
            "features": {
                "keywords": [
                    "沪深股通",
                    "外资买入",
                    "板块偏好"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "消费",
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "掘金沪深股通：外资昨净买入78只个股超千万元 最爱这四个板块",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-10",
            "original_text": "中国个股：恒瑞医药向美TG公司授权新药研发许可，可获3.5亿美元加销售提成",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "新药研发",
                    "授权许可",
                    "销售提成"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中国个股：恒瑞医药向美TG公司授权新药研发许可，可获3.5亿美元加销售提成",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-10",
            "original_text": "沪指八连阳 ‘喝酒吃药’行情再现",
            "features": {
                "keywords": [
                    "沪指八连阳",
                    "白酒",
                    "医药",
                    "行情"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "白酒",
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沪指八连阳 ‘喝酒吃药’行情再现",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-01-09",
            "original_text": "BTK抑制剂授权海外，创新药国际化再下一城",
            "features": {
                "keywords": [
                    "BTK抑制剂",
                    "海外授权",
                    "国际化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "BTK抑制剂授权海外，创新药国际化再下一城",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]